StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)

Close on Nov 17, 2026Market cap $947.51KP/E –Yield –

Oragenics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Oragenics's revenue for the twelve months ending Dec 31, 2023 was $37.65K, down 71.4% year over year. For fiscal 2023 it was $37.65K, down 71.4% from the year before. Over ten years it grew -29.9% a year on average. The highest annual figure on record is $1.44M in fiscal 2011.

Annual revenue

PeriodPeriod endValueChange
FY2023Dec 31, 2023$37.65K-71.4%
FY2022Dec 31, 2022$131.52K+51.2%
FY2021Dec 31, 2021$86.99K–
FY2017Dec 31, 2017$0–
FY2016Dec 31, 2016$0–
FY2015Dec 31, 2015$0-100.0%
FY2014Dec 31, 2014$939.93K-8.9%
FY2013Dec 31, 2013$1.03M-22.5%
FY2012Dec 31, 2012$1.33M-7.8%
FY2011Dec 31, 2011$1.44M+10.4%
FY2010Dec 31, 2010$1.31M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$7.47K-91.3%
Q2 FY2023Jun 30, 2023$13.16K-56.7%
Q1 FY2023Mar 31, 2023$17.02K+12.9%
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$86.05K–
Q2 FY2022Jun 30, 2022$30.39K–
Q1 FY2022Mar 31, 2022$15.08K–
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$0–
Q2 FY2018Jun 30, 2018$0–
Q1 FY2018Mar 31, 2018$0–
Q4 FY2017Dec 31, 2017$0–
Q3 FY2017Sep 30, 2017$0–
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$0–
Q4 FY2016Dec 31, 2016$0–
Q3 FY2016Sep 30, 2016$0–

More Oragenics figures

See a number that looks wrong?